MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Halozyme Therapeutics Company Profile (NASDAQ:HALO)

Consensus Ratings for Halozyme Therapeutics (NASDAQ:HALO) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $19.67 (11.01% downside)

Analysts' Ratings History for Halozyme Therapeutics (NASDAQ:HALO)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2015JPMorgan Chase & Co.Boost Price TargetOverweight$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Piper JaffrayReiterated RatingOverweight$19.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015JMP SecuritiesBoost Price TargetBuy$17.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015MLV & Co.Reiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015BMO Capital MarketsSet Price TargetBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015MLV & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015MLV & Co.Initiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015BMO Capital MarketsBoost Price TargetBuy$24.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015MLV & Co.Boost Price TargetBuy$15.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015JPMorgan Chase & Co.Boost Price TargetOverweight$12.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Piper JaffrayBoost Price Target$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015MLV & Co.Initiated CoverageBuy$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/24/2014MLV & Co.Initiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014JPMorgan Chase & Co.Lower Price TargetOverweight$13.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014Jefferies GroupReiterated RatingUnderperform$4.50 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2014JPMorgan Chase & Co.Initiated CoverageOverweight$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2014Citigroup Inc.Initiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2014BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2014Jefferies GroupBoost Price Target$4.00 -> $4.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysReiterated RatingEqual Weight$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013BMO Capital MarketsBoost Price Target$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013BarclaysBoost Price TargetEqual Weight$8.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/2/2013Jefferies GroupLower Price TargetUnderperform$4.50 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/2/2013BarclaysDowngradeOverweight -> Equal Weight$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)